Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
33%
Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (33.3%)
N/A4 (66.7%)

Trials by Status

not_yet_recruiting117%
completed467%
active_not_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6